The cholera genome: an advance for science or for medicine?

genome sequence will help in developing protection against the disease. Robert Walgate discovers that it might - but perhaps not in the most obvious ways.

Written byRobert Walgate
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

LONDON, 8 August (Science Analysed) So, we have the genome sequence of Vibrio cholerae, a fascinating organism for research, with its two circular chromosomes, its complex estuarine and marine ecology involving plankton and bacteriophage, a history of gene hopping and its links not only to many gut bacteria — including Escherichia coli — but also to a wide variety of organisms important in the marine biota. This will clearly be a treasure trove for science.

But is it of use to medicine, as some media reports and some scientists have hinted? Let's get some perspective. A quarter of a million cases of cholera, 3.6% of which (9135) were fatal, were reported to WHO in 1999. But those figures exclude Bangladesh, historically the prime focus of the disease, which does not report its cholera cases to WHO, and where experts estimate there are probably 400,000–600,000 cases a year and maybe 5000 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems